8 reports of this reaction
3.2% of all DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE, manufactured by Kenvue Brands LLC. There are 8 FDA adverse event reports linking DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE to FATIGUE. This represents approximately 3.2% of all 251 adverse event reports for this drug.
Patients taking DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 8 FDA reports for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.2% of all adverse event reports for DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE, making it one of the most commonly reported side effect.
If you experience fatigue while taking DIPHENHYDRAMINE HYDROCHLORIDE AND ZINC ACETATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.